{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:11:57Z","timestamp":1787224317653,"version":"build-2736575974"},"reference-count":106,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Pediatric solid organ transplant is a life-saving procedure for children with end-stage organ failure. Viral infections are a common complication following pediatric solid organ transplantation (SOT), which can lead to increased morbidity and mortality. Pediatric solid organ transplant recipients are at an increased risk of viral infections due to their immunosuppressed state. The most commonly encountered viruses include cytomegalovirus (CMV), Epstein-Barr virus (EBV), herpes simplex virus (HSV), varicella-zoster virus (VZV), adenoviruses, and BK polyomavirus. Prevention strategies include vaccination prior to transplantation, post-transplant prophylaxis with antiviral agents, and preemptive therapy. Treatment options vary depending on the virus and may include antiviral therapy and sometimes immunosuppression modification. This review provides a Quick Algorithmic overview of prevention and treatment strategies for viral infectious diseases in pediatric solid organ transplant recipient.<\/jats:p>","DOI":"10.3389\/fped.2023.1252495","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T06:20:50Z","timestamp":1693808450000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["A quick algorithmic review on management of viral infectious diseases in pediatric solid organ transplant recipients"],"prefix":"10.3389","volume":"11","author":[{"given":"Marjan","family":"Moghadamnia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Eshaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hosein","family":"Alimadadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Dashti-Khavidaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/MOT.0000000000000224","article-title":"Overview of pediatric organ transplantation: current opinion and future perspectives on immunosuppression","volume":"20","author":"Malik","year":"2015","journal-title":"Curr Opin Organ Transplant"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1093\/cid\/ciz1113","article-title":"Burden and timeline of infectious diseases in the first year after solid organ transplantation in the Swiss Transplant Cohort Study","volume":"71","author":"Van Delden","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e1302","DOI":"10.1093\/cid\/ciaa1189","article-title":"Immunosuppressive agents and infectious risk in transplantation: managing the \u201cnet state of immunosuppression\u201d","volume":"73","author":"Roberts","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/ajt.14208","article-title":"Infection in organ transplantation","volume":"17","author":"Fishman","year":"2017","journal-title":"Am J Transplant"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e2310687-e","DOI":"10.1001\/jamanetworkopen.2023.10687","article-title":"Vaccine-preventable infections among solid organ transplant recipients in Switzerland","volume":"6","author":"Walti","year":"2023","journal-title":"JAMA Netw Open"},{"key":"B6","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1097\/TP.0000000000000888","article-title":"Cytomegalovirus infection in pediatric renal transplantation and the impact of chemoprophylaxis with (val-) ganciclovir","volume":"100","author":"H\u00f6cker","year":"2016","journal-title":"Transplantation"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e13652","DOI":"10.1111\/ctr.13652","article-title":"Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Allen","year":"2019","journal-title":"Clin Transplant"},{"key":"B8","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00134-019-05597-y","article-title":"Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients","volume":"45","author":"Timsit","year":"2019","journal-title":"Intensive Care Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.idc.2021.11.004","article-title":"Antiviral therapeutics in pediatric transplant recipients","volume":"36","author":"Otto","year":"2022","journal-title":"Clin Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e20200696","DOI":"10.1542\/peds.2020-0696","article-title":"Care of pediatric solid organ transplant recipients: an overview for primary care providers","volume":"146","author":"Katz","year":"2020","journal-title":"Pediatrics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.3390\/v15051059","article-title":"Epidemiology and risk factors for viral infections in pediatric liver transplant recipients and impact on outcome","volume":"15","author":"Abdullatif","year":"2023","journal-title":"Viruses"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ajt.12093","article-title":"Introduction: infections in solid organ transplantation","volume":"13","author":"Green","year":"2013","journal-title":"Am J Transplant"},{"key":"B13","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1399-0012.1991.tb00101.x","article-title":"OKT3 And viral disease in pediatric liver transplant recipients","volume":"5","author":"Bowman","year":"1991","journal-title":"Clin Transplant"},{"key":"B14","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1097\/TP.0000000000001531","article-title":"Effectiveness of preemptive therapy for cytomegalovirus disease in pediatric liver transplantation","volume":"101","author":"Nicastro","year":"2017","journal-title":"Transplantation"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1097\/TP.0b013e3181a19cda","article-title":"A hybrid strategy for the prevention of cytomegalovirus-related complications in pediatric liver transplantation recipients","volume":"87","author":"Madan","year":"2009","journal-title":"Transplantation"},{"key":"B16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/TP.0b013e31817889e4","article-title":"Prophylaxis followed by preemptive therapy versus preemptive therapy for prevention of human cytomegalovirus disease in pediatric patients undergoing liver transplantation","volume":"86","author":"Gerna","year":"2008","journal-title":"Transplantation"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e13512","DOI":"10.1111\/ctr.13512","article-title":"Cytomegalovirus in solid organ transplant recipients\u2014guidelines of the American society of transplantation infectious diseases community of practice","volume":"33","author":"Razonable","year":"2019","journal-title":"Clin Transplant"},{"key":"B18","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/jpids\/pis056","article-title":"Assessment of cytomegalovirus hybrid preventative strategy in pediatric heart transplant patients","volume":"1","author":"Lin","year":"2012","journal-title":"J Pediatric Infect Dis Soc"},{"key":"B19","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/TP.0000000000002191","article-title":"The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"102","author":"Kotton","year":"2018","journal-title":"Transplantation"},{"key":"B20","volume-title":"Pediatric liver transplantation: A clinical guide","author":"Hadzic","year":"2020"},{"key":"B21","year":""},{"key":"B22","doi-asserted-by":"publisher","first-page":"338","DOI":"10.4254\/wjh.v14.i2.338","article-title":"Cytomegalovirus infection in liver-transplanted children","volume":"14","author":"Onpoaree","year":"2022","journal-title":"World J Hepatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/j.1600-6143.2008.02528.x","article-title":"Valganciclovir dosing according to body surface area and renal function in pediatric solid organ transplant recipients","volume":"9","author":"Vaudrya","year":"2009","journal-title":"Am J Transplant"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1098434","DOI":"10.3389\/fped.2023.1098434","article-title":"Prevention and management of CMV infection in pediatric solid organ transplant recipients","volume":"11","author":"Balani","year":"2023","journal-title":"Front Pediatr"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1111\/ajt.16423","article-title":"Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): a nationwide cohort study","volume":"21","author":"Walti","year":"2021","journal-title":"Am J Transplant"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1085101","DOI":"10.3389\/fped.2022.1085101","article-title":"Valganciclovir is not associated with decreased EBV infection rate in pediatric kidney transplantation","volume":"10","author":"Cheyssac","year":"2022","journal-title":"Front Pediatr"},{"key":"B27","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/s41390-019-0523-4","article-title":"Valganciclovir prophylaxis delays onset of EBV viremia in high-risk pediatric solid organ transplant recipients","volume":"87","author":"Albatati","year":"2020","journal-title":"Pediatr Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e12816","DOI":"10.1111\/petr.12816","article-title":"The efficacy of valganciclovir for prevention of infections with cytomegalovirus and Epstein-Barr virus after kidney transplant in children","volume":"21","author":"Cameron","year":"2017","journal-title":"Pediatr Transplant"},{"key":"B29","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/j.1432-2277.2012.01485.x","article-title":"(Val-) ganciclovir prophylaxis reduces Epstein-Barr virus primary infection in pediatric renal transplantation","volume":"25","author":"H\u00f6cker","year":"2012","journal-title":"Transpl Int"},{"key":"B30","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/tri.13085","article-title":"Impact of antiviral prophylaxis in adults Epstein\u2013Barr Virus-seronegative kidney recipients on early and late post-transplantation lymphoproliferative disorder onset: a retrospective cohort study","volume":"31","author":"Ville","year":"2018","journal-title":"Transpl Int"},{"key":"B31","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/ajt.14020","article-title":"The role of antiviral prophylaxis for the prevention of epstein\u2013barr virus\u2013associated posttransplant lymphoproliferative disease in solid organ transplant recipients: a systematic review","volume":"17","author":"AlDabbagh","year":"2017","journal-title":"A J Transplant"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e14350","DOI":"10.1111\/petr.14350","article-title":"The IPTA Nashville consensus conference on post-transplant lymphoproliferative disorders after solid organ transplantation in children: II\u2014consensus guidelines for prevention","author":"Green","year":"2022","journal-title":"Pediatr Transplant"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1087864","DOI":"10.3389\/fped.2022.1087864","article-title":"Post-transplant lymphoproliferative disease after pediatric kidney transplant","volume":"10","author":"Fulchiero","year":"2022","journal-title":"Front Pediatr"},{"key":"B34","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/MOT.0b013e3283186ba9","article-title":"Epstein\u2013Barr virus, rapamycin, and host immune responses","volume":"13","author":"Krams","year":"2008","journal-title":"Curr Opin Organ Transplant"},{"key":"B35","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41409-019-0699-6","article-title":"Pre-emptive rituximab treatment for Epstein\u2013Barr virus reactivation after allogeneic hematopoietic stem cell transplantation is a worthwhile strategy in high-risk recipients: a comparative study for immune recovery and clinical outcomes","volume":"55","author":"Stocker","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"B36","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/MOH.0000000000000083","article-title":"EBV Lymphoproliferative disease after hematopoietic stem cell transplant","volume":"21","author":"Rouce","year":"2014","journal-title":"Curr Opin Hematol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/jcpt.13346","article-title":"Expanded utilization of rituximab in paediatric cardiac transplant patients","volume":"46","author":"Kiskaddon","year":"2021","journal-title":"J Clin Pharm Ther"},{"key":"B38","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/ajt.12640","article-title":"Adapted treatment of Epstein\u2013Barr virus infection to prevent posttransplant lymphoproliferative disorder after heart transplantation","volume":"14","author":"Choquet","year":"2014","journal-title":"A J Transplant"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e13526","DOI":"10.1111\/ctr.13526","article-title":"Herpes simplex virus infections in solid organ transplantation: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Lee","year":"2019","journal-title":"Clin Transplant"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e13622","DOI":"10.1111\/ctr.13622","article-title":"Varicella zoster virus in solid organ transplantation: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Pergam","year":"2019","journal-title":"Clin Transplant"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e13563","DOI":"10.1111\/ctr.13563","article-title":"Vaccination of solid organ transplant candidates and recipients: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Danziger-Isakov","year":"2019","journal-title":"Clin Transplant"},{"key":"B42","doi-asserted-by":"publisher","first-page":"S197","DOI":"10.1086\/522133","article-title":"Varicella vaccination of immunocompromised children","volume":"197","author":"Levin","year":"2008","journal-title":"J Infect Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/archdischild-2020-319822","article-title":"Principles of immunisation in children with solid organ transplant","volume":"106","author":"Kelgeri","year":"2021","journal-title":"Arch Dis Child"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e13571","DOI":"10.1111\/petr.13571","article-title":"Live vaccines after pediatric solid organ transplant: proceedings of a consensus meeting, 2018","volume":"23","author":"Suresh","year":"2019","journal-title":"Pediatr Transplant"},{"key":"B45","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3390\/children9020130","article-title":"Long-term varicella zoster virus immunity in paediatric liver transplant patients can be achieved by booster vaccinations\u2014a single-centre, retrospective, observational analysis","volume":"9","author":"Laue","year":"2022","journal-title":"Children"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e13490","DOI":"10.1111\/petr.13490","article-title":"Measles, mumps, rubella (vaccine) and varicella vaccines in pediatric liver transplant: an initial analysis of post-transplant immunity","volume":"23","author":"Yoeli","year":"2019","journal-title":"Pediatr Transplant"},{"key":"B47","year":""},{"key":"B48","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/pbc.21638","article-title":"Valacyclovir and Acyclovir pharmacokinetics in immunocompromised children","volume":"51","author":"Bomgaars","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"B49","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s004670050764","article-title":"Acyclovir Prophylaxis of varicella in children with renal disease receiving steroids","volume":"14","author":"Goldstein","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S0022-3476(81)80697-X","article-title":"Prophylaxis of varicella in high-risk children: dose-response effect of zoster immune globulin","volume":"98","author":"Orenstein","year":"1981","journal-title":"J Pediatr"},{"key":"B51","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/infdis\/147.4.737","article-title":"Evaluation of varicella-zoster immune globulin: protection of immunosuppressed children after household exposure to varicella","volume":"147","author":"Zaia","year":"1983","journal-title":"J Infect Dis"},{"key":"B52","volume-title":"Red Book: 2018-2021 report of the committee on infectious diseases","author":"Kimberlin","year":"2018"},{"key":"B53","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1136\/adc.69.6.639","article-title":"Effect of oral Acyclovir against primary and secondary viraemia in incubation period of varicella","volume":"69","author":"Suga","year":"1993","journal-title":"Arch Dis Child"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1093\/cid\/ciy294","article-title":"A 5-year prospective multicenter evaluation of influenza infection in transplant recipients","volume":"67","author":"Kumar","year":"2018","journal-title":"Clin Infect Dis"},{"key":"B55","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/14787210.2020.1713098","article-title":"Influenza in solid organ transplant recipients: epidemiology, management, and outcomes","volume":"18","author":"Mombelli","year":"2020","journal-title":"Expert Rev Anti Infect Ther"},{"key":"B56","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/jmwh.13203","article-title":"Influenza and influenza vaccine: a review","volume":"66","author":"Nypaver","year":"2021","journal-title":"J Midwifery Womens Health"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e20173021","DOI":"10.1542\/peds.2017-3021","article-title":"Safety and immunogenicity of a recombinant influenza vaccine: a randomized trial","volume":"141","author":"Dunkle","year":"2018","journal-title":"Pediatrics"},{"key":"B58","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3389\/fped.2019.00317","article-title":"Influenza vaccination: effectiveness, indications, and limits in the pediatric population","volume":"7","author":"Mameli","year":"2019","journal-title":"Front Pediatr"},{"key":"B59","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1111\/ajt.16295","article-title":"Alternative strategies of posttransplant influenza vaccination in adult solid organ transplant recipients","volume":"21","author":"Haddadin","year":"2021","journal-title":"Am J Transplant"},{"key":"B60","doi-asserted-by":"publisher","first-page":"526.e1","DOI":"10.1016\/j.eimc.2013.01.013","article-title":"Management of influenza infection in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the spanish society of infectious diseases and clinical microbiology (SEIMC) and the spanish network for research in infectious diseases (REIPI)","volume":"31","author":"L\u00f3pez-Medrano","year":"2013","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e13511","DOI":"10.1111\/ctr.13511","article-title":"RNA Respiratory viral infections in solid organ transplant recipients: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Manuel","year":"2019","journal-title":"Clin Transplant"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciy866","article-title":"Clinical practice guidelines by the infectious diseases society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza","volume":"68","author":"Uyeki","year":"2019","journal-title":"Clin Infect Dis"},{"key":"B63","first-page":"33","article-title":"Hepatitis B virus infection and organ transplantation","volume":"14","author":"Ayoub","year":"2018","journal-title":"Gastroenterol Hepatol (NY)"},{"key":"B64","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2147\/JHC.S306963","article-title":"Clinical, pathological and genetic characteristics of pediatric hepatocellular carcinoma associated with hepatitis B virus infection","volume":"8","author":"Zhao","year":"2021","journal-title":"J Hepatocell Carcinoma"},{"key":"B65","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/MOP.0000000000000391","article-title":"Hepatitis B immunity in the pediatric liver transplant population","volume":"28","author":"Patel","year":"2016","journal-title":"Curr Opin Pediatr"},{"key":"B66","year":""},{"key":"B67","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.15585\/mmwr.mm7126a2","article-title":"Updated US public health service guideline for testing of transplant candidates aged 12 years for infection with HIV, hepatitis B virus, and hepatitis C virus\u2014united States","volume":"22","author":"Free","year":"2022","journal-title":"Am J Transplant"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1111\/ajt.13187","article-title":"Solid organ transplantation from hepatitis B virus\u2013positive donors: consensus guidelines for recipient management","volume":"15","author":"Huprikar","year":"2015","journal-title":"Am J Transplant"},{"key":"B69","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/1751-2980.12066","article-title":"D e novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation","volume":"14","author":"Xi","year":"2013","journal-title":"J Dig Dis"},{"key":"B70","doi-asserted-by":"publisher","first-page":"e13514","DOI":"10.1111\/ctr.13514","article-title":"Viral hepatitis: guidelines by the American society of transplantation infectious disease community of practice","volume":"33","author":"Te","year":"2019","journal-title":"Clin Transplant"},{"key":"B71","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/MPG.0000000000002628","article-title":"Management of hepatitis B virus infection and prevention of hepatitis B virus reactivation in children with acquired immunodeficiencies or undergoing immune suppressive, cytotoxic, or biological modifier therapies","volume":"70","author":"Indolfi","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B72","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ijid.2020.01.035","article-title":"Efficacy and safety of the regimens containing tenofovir alafenamide versus tenofovir disoproxil fumarate in fixed-dose single-tablet regimens for initial treatment of HIV-1 infection: a meta-analysis of randomized controlled trials","volume":"93","author":"Tao","year":"2020","journal-title":"Int J Infect Dis"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2325958220919231","DOI":"10.1177\/2325958220919231","article-title":"A review and clinical understanding of tenofovir: tenofovir disoproxil fumarate versus tenofovir alafenamide","volume":"19","author":"Wassner","year":"2020","journal-title":"JIAPAC"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e14235","DOI":"10.1111\/petr.14235","article-title":"Update on COVID-19 vaccination in pediatric solid organ transplant recipients","volume":"26","author":"Dulek","year":"2022","journal-title":"Pediatr Transplant"},{"key":"B75","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1097\/TP.0000000000004256","article-title":"Factors associated with COVID-19 vaccine response in transplant recipients: a systematic review and meta-analysis","volume":"106","author":"Li","year":"2022","journal-title":"Transplantation"},{"key":"B76","doi-asserted-by":"publisher","first-page":"101839","DOI":"10.1016\/j.trim.2023.101839","article-title":"Serologic response to COVID-19 infection or vaccination in pediatric kidney transplant recipients compared to healthy children","volume":"78","author":"Ziv","year":"2023","journal-title":"Transpl Immunol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"11153","DOI":"10.3389\/ti.2023.11153","article-title":"Optimizing COVID-19 vaccination strategy in pediatric kidney transplant recipients: humoral and cellular response to SARS-CoV-2 mRNA vaccination","volume":"36","author":"Nel","year":"2023","journal-title":"Transpl Int"},{"key":"B78","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00467-021-05256-9","article-title":"Immunologic response of mRNA SARS-CoV-2 vaccination in adolescent kidney transplant recipients","volume":"37","author":"Crane","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00467-022-05679-y","article-title":"Immunologic response to SARS-CoV-2 mRNA vaccination in pediatric kidney transplant recipients","volume":"38","author":"Kermond","year":"2023","journal-title":"Pediatr Nephrol"},{"key":"B80","year":""},{"key":"B81","year":""},{"key":"B82","year":""},{"key":"B83","year":""},{"key":"B84","volume-title":"IDSA Guidelines on the treatment and management of patients with COVID-19","year":"2021"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1097\/TP.0000000000004200","article-title":"Update on COVID-19 therapeutics for solid organ transplant recipients, including the omicron surge","volume":"106","author":"Avery","year":"2022","journal-title":"Transplantation"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1150341","DOI":"10.3389\/fimmu.2023.1150341","article-title":"Optimizing the use of nirmatrelvir\/ritonavir in solid organ transplant recipients with COVID-19: a review of immunosuppressant adjustment strategies","volume":"14","author":"Tang","year":"2023","journal-title":"Front Immunol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3345\/cep.2022.00878","article-title":"COVID-19 in immunocompromised children and adolescents","volume":"66","author":"Kwak","year":"2023","journal-title":"Clin Exp Pediatr"},{"key":"B88","doi-asserted-by":"publisher","first-page":"e13595","DOI":"10.1111\/tid.13595","article-title":"Effect of immunosuppression maintenance in solid organ transplant recipients with COVID-19: systematic review and meta-analysis","volume":"23","author":"Karruli","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"B89","doi-asserted-by":"publisher","first-page":"88","DOI":"10.5500\/wjt.v12.i5.88","article-title":"Pediatric transplantation during the COVID-19 pandemic","volume":"12","author":"Kakos","year":"2022","journal-title":"World J Transplant"},{"key":"B90","year":""},{"key":"B91","doi-asserted-by":"publisher","first-page":"e13527","DOI":"10.1111\/ctr.13527","article-title":"Adenovirus in solid organ transplant recipients: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Florescu","year":"2019","journal-title":"Clin Transplant"},{"key":"B92","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/QCO.0000000000000558","article-title":"Approach to infection and disease due to adenoviruses in solid organ transplantation","volume":"32","author":"Florescu","year":"2019","journal-title":"Curr Opin Infect Dis"},{"key":"B93","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1093\/jac\/dky192","article-title":"Model of population pharmacokinetics of cidofovir in immunocompromised children with cytomegalovirus and adenovirus infection","volume":"73","author":"Neant","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"B94","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/jpids\/piy049","article-title":"Outcomes of human adenovirus infection and disease in a retrospective cohort of pediatric hematopoietic cell transplant recipients","volume":"8","author":"Fisher","year":"2019","journal-title":"Pediatric Infect Dis Soc"},{"key":"B95","doi-asserted-by":"publisher","first-page":"e13510","DOI":"10.1111\/petr.13510","article-title":"Outcomes of human adenovirus infection and disease in a retrospective cohort of pediatric solid organ transplant recipients","volume":"23","author":"Boge","year":"2019","journal-title":"Pediatr Transplant"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.3390\/microorganisms11071750","article-title":"Adenovirus infection in hematopoietic and solid organ paediatric transplant recipients: treatment, outcomes, and use of cidofovir","volume":"11","author":"Grasa","year":"2023","journal-title":"Microorganisms"},{"key":"B97","doi-asserted-by":"publisher","first-page":"10600280231176135","DOI":"10.1177\/10600280231176135","article-title":"Cidofovir for viral infections in immunocompromised children: guidance on dosing, safety, efficacy, and a review of the literature","author":"Riggsbee","year":"2023","journal-title":"Ann Pharmacother"},{"key":"B98","doi-asserted-by":"publisher","first-page":"e13528","DOI":"10.1111\/ctr.13528","article-title":"BK Polyomavirus in solid organ transplantation\u2014guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Hirsch","year":"2019","journal-title":"Clin Transplant"},{"key":"B99","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1038\/s41598-021-82160-0","article-title":"BK Virus infection and outcome following kidney transplantation in childhood","volume":"11","author":"McCaffrey","year":"2021","journal-title":"Sci Rep"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1097\/TP.0000000000002414","article-title":"Epidemiology of and risk factors for BK polyomavirus replication and nephropathy in pediatric renal transplant recipients: an international CERTAIN registry study","volume":"103","author":"Hoecker","year":"2019","journal-title":"Transplantation"},{"key":"B101","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/j.1600-6143.2009.02834.x","article-title":"KDIGO Clinical practice guideline for the care of kidney transplant recipients","volume":"9","author":"Eckardt","year":"2009","journal-title":"Am J Transplant"},{"key":"B102","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/j.1399-3046.2010.01318.x","article-title":"Cost-efficient screening for BK virus in pediatric kidney transplantation: a single-center experience and review of the literature","volume":"14","author":"Laskin","year":"2010","journal-title":"Pediatr Transplant"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21926\/obm.transplant.2303192","article-title":"BK virus infection and its management in renal transplantation: an update","volume":"7","author":"Chakrabarti","year":"2023","journal-title":"OBM Transplant"},{"key":"B104","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.xkme.2020.06.015","article-title":"Advances in BK virus complications in organ transplantation and beyond","volume":"2","author":"Cohen-Bucay","year":"2020","journal-title":"Kidney Medicine"},{"key":"B105","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1097\/TXD.0000000000000641","article-title":"Clearance of BK virus nephropathy by combination antiviral therapy with intravenous immunoglobulin","volume":"3","author":"Kable","year":"2017","journal-title":"Transplant Direct"},{"key":"B106","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.transproceed.2015.01.012","article-title":"Efficacy of intravenous immunoglobulin in the treatment of persistent BK viremia and BK virus nephropathy in renal transplant recipients","volume":"47","author":"Vu","year":"2015","journal-title":"Transplant Proc"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1252495\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,27]],"date-time":"2024-10-27T11:38:57Z","timestamp":1730029137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1252495\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,4]]},"references-count":106,"alternative-id":["10.3389\/fped.2023.1252495"],"URL":"https:\/\/doi.org\/10.3389\/fped.2023.1252495","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,4]]},"article-number":"1252495"}}